HUMAN PAPILLOMA VIRUS INFECTION TYPE 16

Clinical trials for HUMAN PAPILLOMA VIRUS INFECTION TYPE 16 explained in plain language.

Never miss a new study

Get alerted when new HUMAN PAPILLOMA VIRUS INFECTION TYPE 16 trials appear

Sign up with your email to follow new studies for HUMAN PAPILLOMA VIRUS INFECTION TYPE 16, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

New vaccine aims to clear HPV and reverse cervical precancer

Disease control Not yet recruiting

This study is testing an experimental vaccine called PVX4 to see if it can help the body clear HPV16 infection and reverse high-grade precancerous cervical lesions (CIN2/3). It will enroll about 138 women aged 18-60 who have confirmed HPV16+ CIN2/3 and compare the vaccine to a pl…

Matched conditions: HUMAN PAPILLOMA VIRUS INFECTION TYPE 16

Phase: PHASE2 • Sponsor: PapiVax Biotech, Inc. • Aim: Disease control

Last updated Mar 17, 2026 13:08 UTC

HUMAN PAPILLOMA VIRUS INFECTION TYPE 16

Get alerted when new HUMAN PAPILLOMA VIRUS INFECTION TYPE 16 trials appear

New vaccine aims to clear HPV and reverse cervical precancer